Cargando…
Case Reports of Pembrolizumab-induced Acute Inflammatory Demyelinating Polyneuropathy
Pembrolizumab is a humanized monoclonal antibody that blocks the programmed cell death 1 (PD-1) pathway, thereby enhancing antitumor immunity. As the use of immune checkpoint inhibitors becomes more prevalent, so do immune-related adverse events associated with their use. The immune-related adverse...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257738/ https://www.ncbi.nlm.nih.gov/pubmed/30510881 http://dx.doi.org/10.7759/cureus.3371 |